133 facility delivery; non-skilled delivery attendance; and, inappropriate immunization and 134 treatment of sick infants [26] [27] [28] [29] [30] .
135 136 Estimates of neonatal mortality rates and effects of iron-supplements and intermittent 137 prevention and treatment of malaria in pregnancy on neonatal mortality have been reported in 138 recent studies undertaken in south Asia and sub-Saharan Africa regions [14, 16, 24, [32] [33] [34] [35] .
139 However, most of these studies treated neonatal period as a single age block and ignored the 140 non-uniform shape of age pattern of mortality during neonatal period. In Kenya, provision of 141 iron-supplements and anti-malaria drugs during pregnancy are part of the Antenatal Care 142 (ANC) services package. The main objective of this study was to analyse variations in 143 neonatal age segments mortality rates in Kenya's high and low prone malaria areas by uptake 144 of these two ANC services at community level. The secondary objective was to determine 145 the effects of community uptake of these ANC services on neonatal age segments mortality 146 risks in Kenya's high and low prone malaria areas. 258 55.6%); and, mode of delivery (not caesarean section and caesarean section).
260
In age segment period 8 days to less than 1 month, only one socio-demographic and 261 birth characteristics factor was used as control variable and this was HIV positive pregnant 262 women per 10,000 population (categories same as in the first two age segments). Two Table 3 provides odds ratios with 95% CI and p-values for community uptake of iron-408 supplements and anti-malaria drugs during pregnancy variables on risk of child death during 409 the period 1 to 7 days in Kenya's malaria areas. The strategy used to undertake regression 410 analysis for the first neonatal age segment (day of birth) was replicated in this second age 411 segment. However, the only difference was on the adjustment variables used. Five socio-412 demographic and birth characteristics variables (HIV positive pregnant women per 10,000 413 population; preceding birth interval length in months; birth type; elevated birth order risk;
414 and, maternal education) were used as adjustment variables in the three regression models 415 fitted. Two variables associated with antenatal, delivery and post-delivery care services 416 (proportion in community with required tetanus injections during pregnancy; and, mode of 417 delivery) were also included as control variables in the three regression models. Degrees of freedom 7 7 8 p-value 0.000 *** 0.000 *** 0.000 *** 418 Table 3 . Odds ratios for mortality during the period 1 to 7 days for study ANC services 419 and adjustment variables in Kenya's malaria areas.
Model 1 (Malaria low prone area)

Model 2 (Malaria high prone area)
Both zone Model 3 (All areas) Variable
Odds ratio (95% CI)
pvalue
p-value
Odds ratio ( 95% CI)
Community uptake of ANC service during pregnancy Table 4 . Odds ratios for mortality during the period 8 days to less than a month for 461 study ANC services and adjustment variables in Kenya's malaria areas.
Model 1 (Malaria low prone area)
Model 2 (Malaria high prone area)
Both zone Model 3 (All areas) Variable
Odds ratio (95% CI) p-value Odds ratio (95% CI) p-value Odds ratio (95% CI) p-value
Community uptake of ANC service during pregnancy 486 analysis show that in both high and low malaria prone areas, the force of mortality is greatest 487 in the second age segment (1 to 7 days) followed by the first segment (day of birth) and 488 lowest in the last age segment (8 days to less than one month). Based on the mortality rates 489 obtained, the contribution of early neonatal mortality (0 to 7 days) to Kenya's neonatal 490 mortality rate is about 75%. Its contribution to neonatal mortality rates in low malaria prone 491 areas and high malaria areas are 80% and 100%, respectively.
493
Although the results on mortality rates variations in neonatal age segments are 494 statistically insignificant, the depicted patterns are consistent with the study expectations.
495 Low uptake of the study ANC services treated separately and in combination is associated 496 with higher mortality rates in all age segments in high malaria prone areas in Kenya. The 497 finding that uptake of high iron-supplements and high anti-malaria drugs during pregnancy 498 reduces significantly mortality risks in the third age segment (8 days to less than one month) 499 relative to low iron-supplements and low anti-malaria uptake is generally consistent with 500 earlier findings for south Asia and sub-Saharan Africa regions [14, 16, 24] .
502
The unexpected finding, although statistically insignificant, is that high community 503 uptake of anti-malaria drugs during pregnancy is associated with high neonatal period age 504 segments mortality. This stands in contrast to previous studies, especially with the south Asia 505 study, which indicated that intermittent preventive treatment of malaria in pregnancy is 506 associated with about 31% reduction in neonatal mortality [10] . A possible explanation is that 507 in Kenya, high malaria areas are also high childhood mortality areas and use of anti-malaria 508 drugs for prevention and treatment in the general population is common. In addition, 509 provision of anti-malaria drugs during pregnancy is not restricted to ANC services but can be 510 obtained readily without qualified health personnel's prescription in non-health service 511 outlets including local shops/kiosks. The reported uptake of anti-malaria drugs during 512 pregnancy in 2014 KDHS may have captured uptake of anti-malaria drugs by mothers 513 beyond pregnancy durations.
515
This study also identifies and provides effects of the mortality risk factors which were 516 controlled for in analysing death risks in neonatal age segments in Kenya's malaria areas.
517 The findings show that the number of significant factors associated with broad group of 518 socio-demographic and birth characteristics as well as those associated with antenatal, 519 delivery and post-delivery care services, declined after early neonatal (0 to 7 days). This 520 suggests that in Kenya, further reduction in mortality risk in late neonatal (8 days to less than
